Inflammatory joint conditions like rheumatoid arthritis involve immune system over‑activation that leads to pain, swelling, and joint damage. In this study, researchers used a collagen‑induced arthritis model in rats—a widely accepted laboratory model that mimics key aspects of human inflammatory arthritis—to explore how cannabigerol (CBG) might influence inflammation and related joint symptoms. The goal was […]
Research-Based Information
Clinical and Cognitive Improvement Following Treatment with a Hemp-Derived, Full-Spectrum, Full-Spectrum CBD Shows Improvements in Anxiety, Mood, and Cognitive Performance in Pilot Study (pub. Aug 2025)
Anxiety disorders can significantly impact daily life, affecting sleep, focus, and overall well-being. In this open-label pilot study, researchers evaluated a hemp-derived, full-spectrum cannabidiol (CBD) product in adults experiencing moderate to severe anxiety symptoms. Participants took the CBD formulation daily over a six-week period while researchers tracked changes in anxiety levels, mood, sleep quality, and […]
Cannabigerol (CBG) Shows Neuroprotective Effects After Ischemic Brain Injury in Animal Study (pub. Aug 2025)
Stroke and other forms of cerebral ischemia occur when blood flow to the brain is temporarily reduced, depriving neurons of oxygen and nutrients and often leading to memory loss, inflammation, and long-term brain damage. In this study, researchers investigated whether cannabigerol (CBG)—a non-intoxicating cannabinoid found in hemp—could help protect the brain following transient global cerebral […]